Camsirubicin
Camsirubicin (GPX-150) is a non-cardiotoxic Doxorubicin (HY-15142) analog that selectively targets topoisomerase IIβ. Camsirubicin reduces cell viability and clone formation of MDA-MB-468 breast cancer cells. Camsirubicin increases the exposure of CALR and HSP90 on the cell surface. Camsirubicin can be used for the study of breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 236095-26-4
- Formula: C27H32N2O9
- Molecular Weight:528.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
|
topoisomerase II beta |
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 236095-26-4
-
Molecular Weight 528.55
-
Formula C27H32N2O9
-
SMILES
OC1=C(C[C@](CCO)(O)C[C@@H]2O[C@@](O[C@@H](C)[C@H]3O)([H])C[C@@H]3N)C2=C(O)C(C4=N)=C1C(C5=CC=CC(OC)=C45)=O
-
Synonyms
GPX-150
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Frank NE, et al. Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase IIβ activity and cardiac function in a chronic rabbit model. Invest New Drugs. 2016 Dec;34(6):693-700. [Content Brief]
[2]. Xinxin Song, et al. Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers. Cancer Discov. 2020 Dec;10(12):1872-1893. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)